Guido Ascione (@gu_asc1) 's Twitter Profile
Guido Ascione

@gu_asc1

Cardiac surgeon & Structural Heart interventions @SRValveCenter - Research fellow @crfheart

ID: 1670532124481404928

calendar_today18-06-2023 20:41:27

5 Tweet

51 Followers

134 Following

Juan F. Granada (@jgranadacrf) 's Twitter Profile Photo

🚀 Introducing Cusper, a novel transcatheter device for #AR. Designed to fill regurgitant orifice of #AV, it merges an artificial cusp w/native valve to prevent backflow into LV during diastole. #NYValves2024 📊 👉tctmd.com/slide/transcat… Yair Feld #innovationWithPurpose Guido Ascione

Juan F. Granada (@jgranadacrf) 's Twitter Profile Photo

🌟 Is this the future of #TV regurgitation treatment? 🔍 Meet TriFlO, a unique device featuring 3 anchors positioned at the #TV commissures and polymer leaflets to adapt to irregular shape orifices. #NYValves2024 📊 👉 tctmd.com/slide/percutan… #InnovationWithPurpose Guido Ascione

Juan F. Granada (@jgranadacrf) 's Twitter Profile Photo

💡 Simple may be best for #TTVR in patients with severe #TR. Trillium is a streamlined solution with a shorter implantation time and no echo guidance or general anesthesia needed. 🏥 #NYValves2024 📊 👉 tctmd.com/slide/heteroto… Philipp Lurz #InnovationWithPurpose Guido Ascione

Karl-Philipp Rommel (@kp_rommel) 's Twitter Profile Photo

🤔#TTEER or #TTVR for #TR-related right-#heartfailure❓ Matched analysis by Guido Ascione TCT Conference : 🎯TTVR: better TR ⬇️ 🎯No differences in 1-y death/HFH (~10%)‼️ Lots of ❓remain, but in absence of RCT - big 🦶forward 👀 out for the manuscript soon. #TCT2024 #LuxValve

🤔#TTEER or #TTVR for #TR-related right-#heartfailure❓

Matched analysis by <a href="/gu_asc1/">Guido Ascione</a>  <a href="/TCTConference/">TCT Conference</a> :
🎯TTVR: better TR ⬇️
🎯No differences in 1-y death/HFH (~10%)‼️

Lots of ❓remain, but in absence of RCT - big 🦶forward

👀 out for the manuscript soon.
#TCT2024 #LuxValve
Cardiovascular Research Foundation (@crfheart) 's Twitter Profile Photo

💡 At #NYValves2025, CRF Fellow Dr. Guido Ascione shares key late-breaking findings on the global impact of degenerative mitral valve disease and what it means for transcatheter therapies. 🌍🫀 #CardioEd #CardioResearch

💡 At #NYValves2025, CRF Fellow Dr. Guido Ascione shares key late-breaking findings on the global impact of degenerative mitral valve disease and what it means for  transcatheter therapies. 🌍🫀

#CardioEd #CardioResearch
Pier Pasquale Leone (@leoneppmd) 's Twitter Profile Photo

Just wrapped an incredible journey as part of the Program Development Committee for NY Valves with Guido Ascione Philipp von Stein Jennifer von Stein! 🚀 Innovation, insight and inspiration - #NYValves2025 delivered. Until next time! 🔧🫀 #NYValves Cardiovascular Research Foundation

Just wrapped an incredible journey as part of the Program Development Committee for NY Valves with <a href="/gu_asc1/">Guido Ascione</a> <a href="/philippvstein/">Philipp von Stein</a> <a href="/JennifervStein/">Jennifer von Stein</a>! 🚀

Innovation, insight and inspiration - #NYValves2025 delivered. Until next time! 🔧🫀 #NYValves <a href="/crfheart/">Cardiovascular Research Foundation</a>